Leo Melamed is Director at CME GROUP INC. (CME). They have made 5 open-market trades across 1 company since 2006, most recently 2018-02-05.
CIK 0001212838
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CME | 10,537 | $3.2M |
Shares reported on the most recent Form 4, priced at the 2018-02-07 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CME | SELL | 2018-02-05 | 2018-02-07 | $155.78 | $1.1M | +1.9% | +7.0% | -1.1% |
| CME | SELL | 2008-05-28 | 2008-05-30 | $428.06 | $856K | -5.2% | -0.1% | -0.1% |
| CME | SELL | 2007-03-02 | 2007-03-05 | $543.00 | $543K | -5.2% | -0.1% | -0.1% |
| CME | SELL | 2007-02-14 | 2007-02-16 | $575.64 | $576K | -5.2% | -0.1% | -0.1% |
| CME | SELL | 2006-03-06 | 2006-03-08 | $427.60 | $166K | -5.2% | -0.1% | -0.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.